本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Sol-Gel Technologies

75.40
+4.005.60%
成交量:1.46萬
成交額:105.93萬
市值:2.46億
市盈率:-34.28
高:77.20
開:71.07
低:70.90
收:71.40
52周最高:97.97
52周最低:4.11
股本:326.90萬
流通股本:70.92萬
量比:0.48
換手率:2.06%
股息:- -
股息率:- -
每股收益(TTM):-2.1993
每股收益(LYR):-2.1993
淨資產收益率:-23.72%
總資產收益率:-14.43%
市淨率:10.81
市盈率(LYR):-34.28

資料載入中...

公司資料

公司名字:
Sol-Gel Technologies
交易所:
NASDAQ
成立時間:
1997
員工人數:
28
公司地址:
7 Golda Meir Street,Weizmann Science Park,Ness Ziona,Israel
郵編:
7403650
傳真:
- -
簡介:
Sol-gel Technologies Ltd.1997年10月28日根據以色列國法律註冊成立。該公司是一家創新型皮膚病學公司,擁有兩項NDA批準的成功記錄,以及正在為孤兒適應症開發的先進候選產品管道。Sol-Gel成功研發開創性外用藥物Twyneo和Epsolay,分別獲批用於紅斑痤瘡和炎症性病變的治療。

董事

名稱
職位
Moshe Arkin
Executive Chairman of the Board and interim Chief Executive Officer
Ran Gottfried
Lead Independent Director
Sharon Kochan
Independent Director
Yuval Yanai
Independent Director
Hani Lerman
Director
Itai Arkin
Director

股東

名稱
職位
Moshe Arkin
Executive Chairman of the Board and interim Chief Executive Officer
Itzik Yosef
Chief Operating Officer
Eyal Ben Or
Chief Financial Officer
Michael Glezin
Chief Business Officer
Ofer Toledano
Vice President Research and Development
Ofra Levy Hacham
Vice President Clinical, Regulatory Affairs and Quality